Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) rose 1.5% during mid-day trading on Wednesday . The stock traded as high as €21.80 ($22.95) and last traded at €21.62 ($22.76). Approximately 37,826 shares changed hands during trading, a decline of 92% from the average daily volume of 500,026 shares. The stock had previously closed at €21.30 ($22.42).
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd.
Get Our Latest Stock Analysis on Stevanato Group
Stevanato Group Trading Up 2.1 %
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. During the same quarter in the prior year, the business earned $0.16 earnings per share. The company’s quarterly revenue was up 2.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.
Hedge Funds Weigh In On Stevanato Group
Several institutional investors have recently modified their holdings of the business. Hardy Reed LLC increased its stake in shares of Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after buying an additional 840 shares during the period. Lindenwold Advisors INC increased its position in shares of Stevanato Group by 13.5% in the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after purchasing an additional 1,415 shares during the last quarter. Captrust Financial Advisors raised its holdings in shares of Stevanato Group by 12.7% in the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock valued at $262,000 after purchasing an additional 1,480 shares in the last quarter. Raymond James Trust N.A. lifted its position in shares of Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after purchasing an additional 1,613 shares during the last quarter. Finally, First Bank & Trust grew its stake in shares of Stevanato Group by 29.1% during the third quarter. First Bank & Trust now owns 14,109 shares of the company’s stock worth $282,000 after purchasing an additional 3,182 shares in the last quarter.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Great CPU Race: AMD and Intel Battle for Dominance
- What is a Stock Market Index and How Do You Use Them?
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Manufacturing Stocks Investing
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.